Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

INTRODUCTION: Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Nadine, Wang, Yihong, Collins, Laura C, Kaplan, Jennifer, Li, Hailun, Gelman, Rebecca, Comander, Amy H, Gallagher, Bridget, Fetten, Katharina, Krag, Karen, Stoeckert, Kathryn A, Legare, Robert D, Sgroi, Dennis, Ryan, Paula D, Garber, Judy E, Schnitt, Stuart J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://www.ncbi.nlm.nih.gov/pubmed/20149218
http://dx.doi.org/10.1186/bcr2478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://www.ncbi.nlm.nih.gov/pubmed/20149218
http://dx.doi.org/10.1186/bcr2478

Ejemplares similares